A significant higher expression of KCa3.1 (kcnn4 gene) was observed in CD11b+ cells isolated from the ipsilateral cerebral hemisphere of glioma-bearing mice in comparison with the contralateral hemisphere and this difference was totally abolished by TRAM-34 treatment (Figure 3a, left). Here, KCNN4 is linked to central nervous system cancer.